Joan Vinent Genestar
Investigador pre-doc
Research group
Professional network profiles
Last Publications
- López-Ramos MG, Vinent-Genestar J, Aarnoutse R, Colbers A, Velasco E, Martorell-Sampol L, Falcón-Neyra L, Neth O, Prieto L, Guillén S, Baquero-Artigao F, Méndez-Echevarría A, Gómez-Pastrana D, Jiménez AB, Lahoz R, Ramos-Amador JT, Soriano-Arandes A, Santiago B, Rosa Farré Riba, Fortuny-Guasch C, Soy D and Noguera-Julián A Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age ANTIBIOTICS-BASEL . 12(2): .
- Bossacoma F, Cuadrado-Vilanova M, Vinent-Genestar J, Correa MG, Gavrus D, Castillo H, Català-Mora J, Mora J, Schaiquevich P, Chantada G and Carcaboso AM Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection OPHTHALMIC GENETICS . 41(4): 397-400.
- Moreno-Martínez ME, Vinent-Genestar J, Muñoz-Sánchez C and Carreras-Soler MJ Hospital pharmacist's roles and responsibilities with CAR-T medicines FARMACIA HOSPITALARIA . 44(1): 26-31.
Projects
- Project name:
- Estudio multicéntrico fase 2 en pacientes pediátricos (0-18 años) con leucmeia linfoblástica aguda B CD19+ en recaída o refractaria
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI21/00033
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Validación de la dosis única diaria de isoniazida a 10 mg/kg de peso en el lactante menor de 3 meses de vida.
- Leader
- Antoni Noguera Julián
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI13/01740
- Starting - finishing date:
- 2014 - 2018